Literature DB >> 11112109

Outcomes of contact investigations of infectious tuberculosis patients.

S M Marks1, Z Taylor, N L Qualls, R J Shrestha-Kuwahara, M A Wilce, C H Nguyen.   

Abstract

The objective of this study was to describe outcomes of tuberculosis (TB) contact investigations, factors correlated with those outcomes, and current successes and ways to improve TB contact investigations. We abstracted clinic records of a representative U.S. urban sample of 1,080 pulmonary, sputum-smear(+) TB patients reported to CDC July 1996 through June 1997 and the cohort of their 6,225 close contacts. We found a median of four close contacts per patient. Fewer contacts were identified for homeless patients. A visit to the patient's residence resulted in two additional (especially child) contacts identified. Eighty-eight percent of eligible contacts received tuberculin skin tests (TSTs). Recording the last exposure date to the infectious patient facilitated follow-up TST provision. Thirty-six percent of contacts were TST(+). Household contacts and contacts to highly smear(+) or cavitary TB patients were most likely to be TST(+). Seventy-four percent of TST(+) contacts started treatment for latent TB infection (LTBI), of whom 56% completed. Sites using public health nurses (PHNs) started more high-risk TST(-) contacts on presumptive treatment for LTBI. Using directly observed treatment (DOT) increased the likelihood of treatment completion. We documented outcomes of contact investigation efforts by urban TB programs. We identified several successful practices, as well as suggestions for improvements, that will help TB programs target policies and procedures to enhance contact investigation effectiveness.

Entities:  

Mesh:

Year:  2000        PMID: 11112109      PMCID: PMC5448278          DOI: 10.1164/ajrccm.162.6.2004022

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

Review 1.  Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

2.  Infectivity of pulmonary tuberculosis in relation to sputum status.

Authors:  J B SHAW; N WYNN-WILLIAMS
Journal:  Am Rev Tuberc       Date:  1954-05

3.  Impact of policy and practice on the effectiveness of contact screening for tuberculosis.

Authors:  C R MacIntyre; A J Plant
Journal:  Prev Med       Date:  1998 Nov-Dec       Impact factor: 4.018

4.  Guidelines for the investigation and management of tuberculosis contacts.

Authors:  M D Iseman; R R Bentz; R I Fraser; M O Locks; J H Ostrow; E M Sewell
Journal:  Am Rev Respir Dis       Date:  1976-08

5.  Containment of tuberculosis. Preventive therapy with isoniazid, and contact investigation.

Authors:  M D Iseman
Journal:  Chest       Date:  1979-12       Impact factor: 9.410

6.  Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment. Advisory Council for the Elimination of Tuberculosis (ACET).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-08-13

7.  Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-10-30

8.  Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli.

Authors:  D E Snider; G D Kelly; G M Cauthen; N J Thompson; J O Kilburn
Journal:  Am Rev Respir Dis       Date:  1985-07

9.  Essential components of a tuberculosis prevention and control program. Recommendations of the Advisory Council for the Elimination of Tuberculosis.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1995-09-08
  9 in total
  75 in total

1.  Tuberculosis contact investigation policies, practices, and challenges in 11 U.S. communities.

Authors:  Maureen Wilce; Robin Shrestha-Kuwahara; Zachary Taylor; Noreen Qualls; Suzanne Marks
Journal:  J Public Health Manag Pract       Date:  2002-11

2.  Standardizing contact investigation protocols.

Authors:  L B Gerald; F Bruce; C M Brooks; N Brook; M E Kimerling; R A Windsor; W C Bailey
Journal:  Int J Tuberc Lung Dis       Date:  2003-12       Impact factor: 2.373

3.  Latent tuberculosis: revised treatment guidelines.

Authors:  Erica Weir; David N Fisman
Journal:  CMAJ       Date:  2003-10-28       Impact factor: 8.262

4.  Recommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts.

Authors:  Richard Long; Stan Houston; Earl Hershfield
Journal:  CMAJ       Date:  2003-10-14       Impact factor: 8.262

5.  A relook at preventive therapy for tuberculosis in children.

Authors:  Varinder Singh; Soumya Patra
Journal:  Indian J Pediatr       Date:  2010-10-27       Impact factor: 1.967

6.  Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.

Authors:  D Shepardson; S M Marks; H Chesson; A Kerrigan; D P Holland; N Scott; X Tian; A S Borisov; N Shang; C M Heilig; T R Sterling; M E Villarino; W R Mac Kenzie
Journal:  Int J Tuberc Lung Dis       Date:  2013-12       Impact factor: 2.373

7.  Tuberculosis incidence among contacts of active pulmonary tuberculosis.

Authors:  M Cailleaux-Cezar; D de A Melo; G M Xavier; C L G de Salles; F C Q de Mello; A Ruffino-Netto; J E Golub; A Efron; R E Chaisson; M B Conde
Journal:  Int J Tuberc Lung Dis       Date:  2009-02       Impact factor: 2.373

8.  Risk factors for transmission of tuberculosis among United States-born African Americans and Whites.

Authors:  M A Pagaoa; R A Royce; M P Chen; J E Golub; A L Davidow; Y Hirsch-Moverman; S M Marks; L D Teeter; P M Thickstun; D J Katz
Journal:  Int J Tuberc Lung Dis       Date:  2015-12       Impact factor: 2.373

9.  DNA fingerprinting of Mycobacterium tuberculosis isolates from epidemiologically linked case pairs.

Authors:  Diane E Bennett; Ida M Onorato; Barbara A Ellis; Jack T Crawford; Barbara Schable; Robert Byers; J Steve Kammerer; Christopher R Braden
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

10.  Field test of a novel detection device for Mycobacterium tuberculosis antigen in cough.

Authors:  Ruth McNerney; Beyene A Wondafrash; Kebede Amena; Ato Tesfaye; Elaine M McCash; Nicol J Murray
Journal:  BMC Infect Dis       Date:  2010-06-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.